BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22350955)

  • 1. Impact of body mass index in Korean patients with renal cell carcinoma.
    Sung HH; Jeon SS; Park SY; Jeong BC; Seo SI; Lee HM; Choi HY
    Cancer Causes Control; 2012 Mar; 23(3):505-11. PubMed ID: 22350955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.
    Haferkamp A; Pritsch M; Bedke J; Wagener N; Pfitzenmaier J; Buse S; Hohenfellner M
    BJU Int; 2008 May; 101(10):1243-6. PubMed ID: 18261150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.
    Rogde AJ; Gudbrandsdottir G; Hjelle KM; Sand KE; Bostad L; Beisland C
    Scand J Urol Nephrol; 2012 Oct; 46(5):348-57. PubMed ID: 22530756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of body mass index in Korean patients with renal cell carcinoma.
    Jeon HG; Jeong IG; Lee JH; Lee CJ; Kwak C; Kim HH; Lee SE; Lee E
    J Urol; 2010 Feb; 183(2):448-54. PubMed ID: 20006879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
    Parker AS; Lohse CM; Cheville JC; Thiel DD; Leibovich BC; Blute ML
    Urology; 2006 Oct; 68(4):741-6. PubMed ID: 17070345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma.
    Brookman-May S; Kendel F; Hoschke B; Wieland WF; Burger M; Rössler W; May M
    Scand J Urol Nephrol; 2011 Feb; 45(1):5-14. PubMed ID: 20846080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
    Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
    BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patients.
    Schips L; Lipsky K; Zigeuner R; Gidaro S; Salfellner M; Rehak P; Pummer K; Hubmer G
    J Surg Oncol; 2004 Nov; 88(2):57-61; discussion 61-2. PubMed ID: 15499606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
    Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
    BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC).
    Ko K; Park YH; Lee JW; Ku JH; Kwak C; Kim HH
    BJU Int; 2013 Oct; 112(6):775-80. PubMed ID: 24028765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.
    Donat SM; Salzhauer EW; Mitra N; Yanke BV; Snyder ME; Russo P
    J Urol; 2006 Jan; 175(1):46-52. PubMed ID: 16406867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
    Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
    Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer.
    Waalkes S; Merseburger AS; Kramer MW; Herrmann TR; Wegener G; Rustemeier J; Hofmann R; Schrader M; Kuczyk MA; Schrader AJ
    Cancer Causes Control; 2010 Nov; 21(11):1905-10. PubMed ID: 20652393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
    Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma.
    Ku JH; Moon KC; Kwak C; Kim HH
    Urology; 2009 Aug; 74(2):359-63. PubMed ID: 19501879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
    Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma.
    Awakura Y; Nakamura E; Ito N; Yamasaki T; Kamba T; Kamoto T; Ogawa O
    Urology; 2007 Jul; 70(1):50-4. PubMed ID: 17656207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.